Cargando…
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
Autores principales: | Hama, Naoki, Kobayashi, Takuto, Han, Nanumi, Kitagawa, Fumihito, Kajihara, Nabeel, Otsuka, Ryo, Wada, Haruka, Lee, Hee-kyung, Rhee, Hwanseok, Hasegawa, Yoshinori, Yagita, Hideo, Baghdadi, Muhammad, Seino, Ken-ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741421/ https://www.ncbi.nlm.nih.gov/pubmed/35028541 http://dx.doi.org/10.1016/j.isci.2021.103713 |
Ejemplares similares
-
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2020) -
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor
por: Nakamura, Takayoshi, et al.
Publicado: (2022) -
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells
por: Han, Nanumi, et al.
Publicado: (2020) -
An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance
por: Han, Nanumi, et al.
Publicado: (2021) -
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin
por: Han, Nanumi, et al.
Publicado: (2023)